En esta página
01WHWK precio
02Instantánea
03Gráfico
04Divisiones de acciones
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
26Mis Métricas
WHWK Whitehawk Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 6, 2026
$3,70
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$1,87mínimo 52 semanas
$5,50máximo 52 semanas
Capitalización Bursátil (MRQ)
$211M
P/E (TTM)
-1.9
BPA (TTM)
$-1.92
Ingresos (TTM)
$0
tus insignias
Rango 52S
$2–$5
Calificación del Analista
BUY
Precio Objetivo
$8
P/E
-1.9
ROE
-45.0%
Margen de Beneficio Neto
-288.3%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
WHWK Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$3.70
Capitalización Bursátil (MRQ)
$211M
P/E (TTM)
-1.9
BPA (TTM)
$-1.92
Ingresos (TTM)
$0
ROE (TTM)
-45.0%
Rango 52S
$2–$5
WHWK Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Divisiones de acciones
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 27 de agosto de 2021 | 1-for-15 | Inversa |
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$7M2018-12-31 → 2025-12-31
BPA$-0.332021-12-31 → 2025-12-31
Flujo de caja libre$-98M2018-12-31 → 2025-12-31
Margen neto-288.3%2018-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | WHWK | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | -1.9promedio 5A ≈-3.2 | ≈-3.2 | · | · | |
| P/S | 24.4promedio 5A ≈15.5 | ≈15.5 | 16.1 | Valor razonable | |
| P/C (MRQ) | 1.2promedio 5A ≈1.7 | ≈1.7 | 2.5 | Infravalorado | |
| Precio / FCF (TTM) | -3.0promedio 5A ≈-6.4 | ≈-6.4 | · | · | |
| Precio / Flujo de Caja (TTM) | -3.0promedio 5A ≈-6.4 | ≈-6.4 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 1.3promedio 5A ≈1.7 | ≈1.7 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | WHWK | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Operating Margin (Margen Operativo) | -1601.1%promedio 5A ≈-2499.6% | ≈-2499.6% | -1113.3% | Débil | |
| EBITDA Margin (Margen EBITDA) | -1600.0%promedio 5A ≈-2497.0% | ≈-2497.0% | -1113.3% | Débil | |
| Pretax Margin (Margen antes de impuestos) | -288.3%promedio 5A ≈-2206.1% | ≈-2206.1% | -688.6% | De primer nivel | |
| Net Profit Margin (Margen de Beneficio Neto) | -288.3%promedio 5A ≈-2206.1% | ≈-2206.1% | -1287.2% | De primer nivel | |
| ROA (TTM) | -42.6%promedio 5A ≈-56.6% | ≈-56.6% | -27.9% | De primer nivel | |
| ROE (TTM) | -45.0%promedio 5A ≈-58.2% | ≈-58.2% | -27.2% | De primer nivel | |
| ROIC | -83.9%promedio 5A ≈-80.4% | ≈-80.4% | -67.7% | Por debajo del promedio |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | WHWK | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 17.4promedio 5A ≈7.6 | ≈7.6 | 7.9 | Liquidez sólida | |
| Quick Ratio (Ratio Rápido) | 10.0promedio 5A ≈7.3 | ≈7.3 | 6.5 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | WHWK | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | -72.5%promedio 5A ≈0.59% | ≈0.59% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | -22.3%promedio 5A ≈7.0% | ≈7.0% | · | · | |
| Revenue CAGR 5Y (Ingresos CAGR 5A) | -12.6% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | WHWK | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.1promedio 5A ≈0.1 | ≈0.1 | 0.1 | En línea | |
| Inventory Turnover (Rotación de Inventario) | 0.3promedio 5A ≈0.7 | ≈0.7 | · | · | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 2.4promedio 5A ≈7.5 | ≈7.5 | 2.6 | Débil | |
| Revenue / Employee (Ingresos / Empleado) | ≈$223.3K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-130.5%
Próximo informe
Nov 04, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 5, 2026 | $-0.20 | $-0.30 | 33.7% |
| 31 de marzo de 2026 | $-0.32 | $-0.36 | 12.1% | |
| 31 de diciembre de 2025 | $-0.34 | $-0.16 | -116.4% | |
| 30 de septiembre de 2025 | $-0.26 | $0.07 | -482.4% | |
| 30 de junio de 2025 | $-0.76 | $0.50 | -251.0% | |
| 31 de marzo de 2025 | $-0.37 | $-0.47 | 21.1% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7M | $26M | $24M | $15M | $14M | $14M | $0 | $20M | |
| Cost of Revenue | $760.0K | $3M | $3M | $1M | $0 | · | · | · | |
| R&D Expense | $91M | $51M | $49M | $33M | $20M | $15M | $13M | $18M | |
| SG&A Expense | $30M | $37M | $45M | $40M | $19M | $2M | $10M | $13M | |
| Operating Expenses | $122M | $93M | $96M | $78M | $112M | $17M | $24M | $31M | |
| Operating Income | $-114M | $-67M | $-72M | $-63M | $-111M | $-3M | $-24M | $-11M | |
| Interest Expense | · | · | $231.0K | $230.0K | $665.0K | $815.0K | · | · | |
| Interest Income | $6M | $4M | $6M | $2M | $13.0K | $41.0K | · | · | |
| Other Non-op | $94M | $4M | $6M | $2M | $1M | $-927.0K | $1M | $784.6K | |
| Pretax Income | $-21M | $-64M | $-66M | $-61M | $-110M | $-3M | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $2.0K | $2.0K | · | · | |
| Net Income | $-21M | $-64M | $-66M | $-61M | $-110M | $-3M | $-23M | $-10M | |
| EPS (Basic) | $-0.33 | $-2.36 | $-2.44 | $-2.69 | $-12.41 | · | · | · | |
| EPS (Diluted) | $-0.33 | $-2.36 | $-2.44 | $-2.69 | $-12.41 | · | · | · | |
| Shares (Basic) | 61,886,765 | 27,029,942 | 26,917,967 | 22,511,237 | 8,923,369 | · | · | · | |
| Shares (Diluted) | 61,886,765 | 27,029,942 | 26,917,967 | 22,511,237 | 8,923,369 | · | · | · | |
| EBITDA | $-114M | $-67M | $-72M | $-63M | $-111M | $-6M | $-24M | $-11M |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $38M | $29M | $63M | $39M | $149M | $4M | $39M | $63M | |
| Short-term Investments | $108M | $19M | $46M | $134M | $0 | · | · | · | |
| Receivables | $0 | $6M | $5M | $2M | $0 | $14M | · | · | |
| Inventory | $0 | $5M | $6M | $2M | $0 | · | · | · | |
| Prepaid Expense | $3M | $3M | $4M | $4M | $2M | $81.0K | $311.2K | $754.4K | |
| Other Current Assets | · | · | · | · | · | $2M | $734.8K | $615.7K | |
| Current Assets | $149M | $61M | $125M | $180M | $151M | $19M | $40M | $64M | |
| PP&E (Net) | $3.0K | $7M | $5M | $508.0K | $57.0K | $21.0K | $164.2K | $98.4K | |
| PP&E (Gross) | $377.0K | $7M | $5M | $609.0K | $87.0K | $512.1K | $493.0K | $409.6K | |
| Accum. Depreciation | $374.0K | $463.0K | $270.0K | $101.0K | $30.0K | $390.3K | $328.9K | $311.1K | |
| Intangibles | · | · | · | $0 | $4M | · | · | · | |
| Other Non-current Assets | $2M | $1M | $2M | $2M | $2M | · | · | · | |
| Total Assets | $151M | $70M | $132M | $184M | $158M | $19M | $40M | $64M | |
| Accounts Payable | $917.0K | $2M | $6M | $4M | $6M | $2M | $439.8K | $595.7K | |
| Accrued Liabilities | $14M | $15M | $14M | $15M | $9M | $4M | · | · | |
| Current Liabilities | $15M | $17M | $26M | $19M | $15M | $30M | $3M | $5M | |
| Capital Leases | $0 | $565.0K | $833.0K | $1M | $474.0K | · | $67.4K | · | |
| Other Non-current Liabilities | $0 | $202.0K | $0 | · | $0 | $97.0K | · | · | |
| Total Liabilities | $15M | $18M | $27M | $26M | $22M | $31M | $3M | $5M | |
| Common Stock | $4.0K | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $4.1K | $4.1K | |
| Retained Earnings | $-353M | $-333M | $-269M | $-203M | $-143M | $-33M | $-142M | $-119M | |
| AOCI | $120.0K | $16.0K | $27.0K | $-115.0K | $0 | · | · | · | |
| Stockholders' Equity | $136M | $52M | $105M | $158M | $136M | $-12M | $-9M | $59M | |
| Liabilities + Equity | $151M | $70M | $132M | $184M | $158M | $19M | $40M | $64M | |
| Shares Outstanding | 47,145,719 | 24,681,000 | 24,554,000 | 24,435,000 | 20,895,000 | 2,542,358 | 40,588,004 | 40,588,004 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $79.0K | $193.0K | $169.0K | $159.0K | $105.0K | $9.0K | · | · | |
| Stock-based Comp | $10M | $11M | $12M | $10M | $2M | $139.0K | $1M | $3M | |
| Deferred Tax | · | · | · | · | $0 | $0 | $0 | $0 | |
| Amort. of Intangibles | · | · | $0 | $87.0K | $95.0K | $0 | · | · | |
| Restructuring | $0 | $3M | $0 | · | · | · | · | · | |
| Other Non-cash | $-87M | $-7M | $-6M | $1M | $85M | · | · | · | |
| Operating Cash Flow | $-97M | $-60M | $-60M | $-50M | $-22M | $-13M | $-24M | $-6M | |
| CapEx | $552.0K | $2M | $4M | $444.0K | $46.0K | $19.0K | $237.0K | $37.9K | |
| Investing Cash Flow | $12M | $25M | $83M | $-133M | $25M | $-19.0K | $-237.0K | $-37.9K | |
| Stock Issued | · | · | · | $0 | $155M | $10M | · | $52M | |
| Net Stock Activity | · | · | · | $0 | $155M | $10M | · | $52M | |
| Dividends Paid | · | · | · | $0 | $4M | · | · | · | |
| Financing Cash Flow | $94M | $130.0K | $326.0K | $73M | $142M | $1M | · | $48M | |
| Net Change in Cash | $9M | $-34M | $24M | $-110M | $145M | $-12M | $-24M | $42M | |
| Free Cash Flow | $-98M | $-61M | $-64M | $-50M | $-22M | $-5M | $-24M | $-6M | |
| Levered FCF | · | · | $-64M | $-50M | $-23M | · | · | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1601.1% | -259.6% | -295.4% | -411.9% | -9930.1% | -42.4% | · | -55.5% | |
| Net Margin | -288.3% | -245.1% | -270.0% | -397.7% | -9829.5% | -28.8% | · | -51.6% | |
| Pretax Margin | -288.3% | -245.1% | -270.0% | -397.7% | -9829.3% | · | · | · | |
| EBITDA Margin | -1600.0% | -258.9% | -294.7% | -410.9% | -9920.7% | -42.4% | · | -55.5% | |
| ROA | -18.6% | -62.8% | -41.5% | -35.4% | -124.6% | -10.2% | -44.7% | -24.4% | |
| ROE | -13.4% | -105.0% | -58.9% | -37.0% | -76.6% | -38.2% | -59.5% | -16.6% | |
| ROIC | -83.9% | -128.6% | -68.4% | -39.6% | -81.5% | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.3 | 3.6 | 4.7 | 9.6 | 9.9 | 24.0 | 11.9 | 11.7 | |
| Quick Ratio | 10.0 | 3.1 | 4.3 | 9.3 | 9.8 | 22.8 | 11.6 | 11.5 | |
| Interest Coverage | · | · | -311.4 | -272.5 | -167.2 | · | · | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.3 | 0.2 | 0.1 | 0.0 | 0.4 | · | 0.5 | |
| Inventory Turnover | 0.3 | 0.5 | 0.7 | 1.4 | · | · | · | · | |
| Receivables Turnover | 2.4 | 4.6 | 6.6 | 16.3 | · | · | · | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.89 | $2.13 | $4.28 | $6.48 | $6.53 | $0.91 | $0.90 | $1.45 | |
| Revenue / Share | $0.12 | $0.96 | $0.90 | $0.68 | · | · | · | · | |
| Cash Flow / Share | $-1.57 | $-2.20 | $-2.22 | $-2.21 | · | · | · | · | |
| Cash / Share | $0.80 | $1.16 | $2.56 | $1.60 | $7.13 | $0.90 | $0.95 | $1.54 | |
| EPS (TTM) | $-0.33 | $-2.36 | $-2.44 | $-2.69 | $-12.41 | · | · | · |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -72.5% | 6.7% | 60.1% | 8.7% | 0.00% | · | · | · | |
| Revenue CAGR 3Y | -22.3% | 22.9% | 20.3% | · | · | · | · | · | |
| Revenue CAGR 5Y | -12.6% | · | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $7M | $26M | $24M | $15M | $14M | $14M | $0 | $20M | |
| Net Income TTM | $-21M | $-64M | $-66M | $-61M | $-110M | $-3M | $-23M | $-10M | |
| Market Cap | $114M | $78M | $50M | $314M | $505M | $695M | $380M | $1.03B | |
| P/E | -7.3 | -1.3 | -0.8 | -4.8 | -1.9 | · | · | · | |
| P/S | 16.0 | 3.0 | 2.0 | 20.6 | 36.0 | 49.6 | · | 51.3 | |
| P/B | 0.8 | 1.5 | 0.5 | 2.0 | 3.7 | 16.1 | 10.4 | 17.6 | |
| P / Tangible Book | 0.8 | 1.5 | 0.5 | 2.0 | 3.8 | · | · | · | |
| P / Cash Flow | -1.2 | -1.3 | -0.8 | -6.3 | -22.5 | -129.0 | -15.9 | -178.2 | |
| P / FCF | -1.2 | -1.3 | -0.8 | -6.3 | -22.5 | -128.5 | -15.8 | -177.0 | |
| Dividend Yield | · | · | · | 0.00% | 0.87% | · | · | · | |
| Earnings Yield | -13.6% | -74.8% | -120.8% | -21.0% | -51.4% | · | · | · | |
| Payout Ratio | · | · | · | 0.00% | -4.0% | · | · | · | |
| Annual Payout | · | · | · | $0 | $4M | · | · | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $7M | $7M | $7M | $6M | $5M | $6M | $6M | $6M | $6M | $5M | $4M | |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $760.0K | $790.0K | $804.0K | $778.0K | $652.0K | $927.0K | $697.0K | $656.0K | $529.0K | $222.0K | $593.0K | |
| R&D Expense | $13M | $17M | $19M | $14M | $49M | $9M | $14M | $10M | $13M | $14M | $13M | $12M | $13M | $11M | $9M | $9M | |
| SG&A Expense | $5M | $6M | $6M | $5M | $6M | $13M | $11M | $7M | $8M | $11M | $10M | $11M | $12M | $11M | $11M | $10M | |
| Operating Expenses | $18M | $24M | $25M | $20M | $55M | $22M | $26M | $21M | $22M | $25M | $24M | $24M | $26M | $23M | $21M | $19M | |
| Operating Income | $-18M | $-24M | $-25M | $-20M | $-55M | $-15M | $-19M | $-13M | $-16M | $-20M | $-18M | $-18M | $-20M | $-17M | $-15M | $-15M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $58.0K | · | $58.0K | $58.0K | $58.0K | $56.0K | $58.0K | |
| Interest Income | $1M | $1M | $2M | $2M | $2M | $791.0K | $676.0K | $906.0K | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $620.0K | |
| Other Non-op | $1M | $1M | $2M | $2M | $2M | $88M | $676.0K | $867.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $562.0K | |
| Pretax Income | $-17M | $-22M | · | · | $-53M | $73M | · | · | · | · | $-16M | $-16M | $-18M | · | $-14M | $-14M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-9.0K | $0 | |
| Net Income | $-17M | $-22M | $-23M | $-18M | $-53M | $73M | $-18M | $-13M | $-15M | $-18M | $-16M | $-16M | $-18M | $-15M | $-14M | $-14M | |
| EPS (Basic) | $-0.20 | $-0.32 | $-1.15 | $-0.26 | $-0.76 | $1.84 | $-0.68 | $-0.46 | $-0.54 | $-0.68 | $-0.60 | $-0.60 | $-0.67 | $-0.57 | $-0.48 | $-0.68 | |
| EPS (Diluted) | $-0.20 | $-0.32 | $-1.14 | $-0.26 | $-0.76 | $1.83 | $-0.68 | $-0.46 | $-0.54 | $-0.68 | $-0.60 | $-0.60 | $-0.67 | $-0.57 | $-0.48 | $-0.68 | |
| Shares (Basic) | 82,886,196 | 69,236,945 | · | 69,204,899 | 69,083,127 | 39,640,826 | · | 27,041,327 | 27,010,013 | 26,980,698 | · | 26,946,683 | 26,879,089 | 26,862,646 | · | 21,269,163 | |
| Shares (Diluted) | 82,886,196 | 69,236,945 | · | 69,204,899 | 69,083,127 | 39,932,539 | · | 27,041,327 | 27,010,013 | 26,980,698 | · | 26,946,683 | 26,879,089 | 26,862,646 | · | 21,269,163 | |
| EBITDA | $-18M | $-24M | · | $-20M | $-55M | $-15M | · | $-13M | $-16M | $-19M | · | $-18M | $-20M | $-17M | · | $-15M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $85M | $35M | $38M | $38M | $145M | $228M | $29M | $31M | $41M | $54M | $63M | $69M | $68M | $34M | $39M | $135M | |
| Short-term Investments | $105M | $88M | $108M | $125M | $32M | $3M | $19M | $32M | $37M | $34M | $46M | $51M | $67M | $117M | $134M | $48M | |
| Receivables | · | · | $0 | $0 | $0 | $0 | $6M | $7M | $6M | $5M | $5M | $6M | $4M | $6M | $2M | $2M | |
| Inventory | · | · | $0 | $0 | $0 | $0 | $5M | $5M | $6M | $6M | $6M | $4M | $3M | $4M | $2M | $734.0K | |
| Prepaid Expense | $2M | $3M | $3M | $2M | $1M | $2M | $3M | $3M | $2M | $3M | $4M | $4M | $3M | $4M | $4M | $4M | |
| Current Assets | $192M | $126M | $149M | $165M | $179M | $233M | $61M | $77M | $93M | $103M | $125M | $133M | $145M | $165M | $180M | $190M | |
| PP&E (Net) | $1.0K | $2.0K | $3.0K | $4.0K | $9.0K | $25.0K | $7M | $6M | $6M | $6M | $5M | $4M | $3M | $2M | $508.0K | $457.0K | |
| PP&E (Gross) | $377.0K | $377.0K | $377.0K | $377.0K | $377.0K | $377.0K | $7M | $6M | $6M | $6M | $5M | $4M | $3M | $2M | $609.0K | · | |
| Accum. Depreciation | $376.0K | $375.0K | $374.0K | $373.0K | $368.0K | $352.0K | $463.0K | $416.0K | $369.0K | $320.0K | $270.0K | $226.0K | $183.0K | $140.0K | $101.0K | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Other Non-current Assets | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Total Assets | $194M | $127M | $151M | $167M | $181M | $234M | $70M | $86M | $102M | $111M | $132M | $140M | $151M | $171M | $184M | $194M | |
| Accounts Payable | $1M | $2M | $917.0K | $2M | $3M | $4M | $2M | $1M | $2M | $3M | $6M | $3M | $3M | $7M | $4M | $4M | |
| Accrued Liabilities | $10M | $9M | $14M | $8M | $5M | $9M | $15M | $14M | $14M | $11M | $14M | $12M | $10M | $11M | $15M | $14M | |
| Current Liabilities | $11M | $11M | $15M | $10M | $9M | $12M | $17M | $16M | $22M | $20M | $26M | $21M | $13M | $18M | $19M | $18M | |
| Capital Leases | · | · | $0 | $0 | $0 | $0 | $565.0K | $624.0K | $682.0K | $738.0K | $833.0K | $946.0K | $1M | $1M | $1M | $1M | |
| Other Non-current Liabilities | · | · | $0 | $0 | $0 | $0 | $202.0K | $393.0K | · | · | $0 | · | · | · | · | · | |
| Total Liabilities | $11M | $11M | $15M | $10M | $9M | $12M | $18M | $17M | $23M | $21M | $27M | $21M | $20M | $25M | $26M | $25M | |
| Common Stock | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | |
| Retained Earnings | $-392M | $-375M | $-353M | $-330M | $-312M | $-260M | $-333M | $-314M | $-302M | $-287M | $-269M | $-253M | $-236M | $-218M | $-203M | $-189M | |
| AOCI | $-63.0K | $-15.0K | $120.0K | $139.0K | $9.0K | $1.0K | $16.0K | $39.0K | $-27.0K | $-8.0K | $27.0K | $-16.0K | $-44.0K | $-32.0K | $-115.0K | $-99.0K | |
| Stockholders' Equity | $183M | $116M | $136M | $157M | $172M | $222M | $52M | $69M | $79M | $90M | $105M | $118M | $131M | $146M | $158M | $169M | |
| Liabilities + Equity | $194M | $127M | $151M | $167M | $181M | $234M | $70M | $86M | $102M | $111M | $132M | $140M | $151M | $171M | $184M | $194M | |
| Shares Outstanding | 57,009,010 | 47,196,564 | 47,145,719 | 47,128,362 | 47,128,362 | 46,784,618 | 24,680,708 | 24,614,834 | 24,614,834 | 24,554,205 | 24,554,205 | 24,525,860 | 24,519,860 | 24,436,990 | 24,435,007 | 24,395,117 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | $50.0K | $44.0K | $44.0K | $43.0K | $38.0K | $46.0K | $12.0K | |
| Stock-based Comp | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $3M | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $-32.0K | $0 | |
| Restructuring | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3M | $0 | $0 | $0 | $0 | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $-5M | · | · | · | $-9M | · | · | |
| Operating Cash Flow | $-15M | $-22M | $-17M | $-15M | $-53M | $-12M | $-15M | $-16M | $-9M | $-20M | $-10M | $-12M | $-17M | $-21M | $-11M | $-8M | |
| CapEx | $0 | $0 | $0 | $0 | $1.0K | $551.0K | $186.0K | $188.0K | $541.0K | $739.0K | $816.0K | $1M | $689.0K | $1M | $78.0K | $102.0K | |
| Investing Cash Flow | $-17M | $19M | $17M | $-92M | $-29M | $115M | $13M | $5M | $-4M | $11M | $4M | $13M | $51M | $16M | $-84M | $-48M | |
| Financing Cash Flow | $82M | $0 | $25.0K | $0 | $-850.0K | $95M | $53.0K | $0 | $87.0K | $-10.0K | $80.0K | $-75.0K | $313.0K | $8.0K | $-107.0K | $73M | |
| Net Change in Cash | $50M | $-3M | $-363.0K | $-107M | $-83M | $199M | $-2M | $-11M | $-13M | $-9M | $-6M | $641.0K | $34M | $-5M | $-96M | $16M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $0 | |
| Free Cash Flow | · | $-22M | · | · | · | $-12M | · | · | · | $-20M | · | · | · | $-23M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -213.0% | · | -186.0% | -252.2% | -364.5% | · | -299.5% | -315.1% | -286.8% | · | -354.2% | |
| Net Margin | · | · | · | · | · | 1021.9% | · | -174.0% | -236.0% | -341.7% | · | -273.6% | -289.8% | -259.5% | · | -341.0% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | · | -273.6% | -289.8% | · | · | -341.0% | |
| EBITDA Margin | · | · | · | · | · | -213.0% | · | -186.0% | -252.2% | -363.6% | · | -299.5% | -315.1% | -286.1% | · | -354.2% | |
| ROA | -8.9% | -12.3% | · | -14.0% | -37.3% | 42.3% | · | -11.1% | -11.5% | -13.0% | · | -9.8% | -12.8% | -9.7% | · | -8.0% | |
| ROE | -9.4% | -13.1% | · | -15.7% | -41.9% | 46.8% | · | -13.4% | -13.9% | -15.5% | · | -11.3% | -15.0% | -11.2% | · | -9.0% | |
| ROIC | -9.9% | -20.2% | · | · | · | · | · | · | · | · | · | -15.1% | -14.9% | · | · | -8.9% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 17.4 | 11.4 | · | 16.8 | 20.4 | 19.0 | · | 4.9 | 4.2 | 5.2 | · | 6.5 | 11.2 | 9.3 | · | 10.6 | |
| Quick Ratio | 17.2 | 11.1 | · | 16.5 | 20.2 | 18.8 | · | 4.4 | 3.8 | 4.7 | · | 6.1 | 10.7 | 8.8 | · | 10.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -336.4 | · | -307.7 | -337.0 | -290.1 | · | -259.2 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | · | · | · | 0.0 | 0.0 | 0.3 | · | 0.2 | 0.2 | 0.1 | · | 0.3 | 0.3 | 0.3 | · | 1.6 | |
| Receivables Turnover | · | · | · | 0.0 | 0.0 | 2.9 | · | 1.2 | 1.3 | 1.0 | · | 1.5 | 2.2 | 1.4 | · | 3.7 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.21 | $2.46 | · | $3.33 | $3.65 | $4.74 | · | $2.80 | $3.20 | $3.68 | · | $4.82 | $5.36 | $5.97 | · | $6.93 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.18 | · | $0.27 | $0.23 | $0.20 | · | $0.22 | $0.23 | $0.22 | · | $0.20 | |
| Cash Flow / Share | · | $-0.32 | · | · | · | $-0.30 | · | · | · | $-0.73 | · | · | · | $-0.79 | · | · | |
| Cash / Share | $1.50 | $0.74 | · | $0.80 | $3.08 | $4.86 | · | $1.24 | $1.67 | $2.19 | · | $2.81 | $2.78 | $1.39 | · | $5.53 | |
| EPS (TTM) | $-1.92 | $-2.48 | · | $0.13 | $-0.07 | $0.15 | · | $-2.28 | $-2.42 | $-2.55 | · | $-2.32 | $-2.40 | $-2.60 | · | · |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $14M | $22M | $28M | · | $25M | $24M | $24M | · | $23M | $22M | $19M | · | $24M | |
| Net Income TTM | $-80M | $-116M | · | $-16M | $-10M | $28M | · | $-62M | $-65M | $-69M | · | $-63M | $-62M | $-62M | · | · | |
| Market Cap | $261M | $163M | · | $90M | $88M | $83M | · | $51M | $36M | $57M | · | $119M | $168M | $177M | · | $345M | |
| P/E | -2.4 | -1.4 | · | 14.6 | -26.7 | 11.9 | · | -0.9 | -0.6 | -0.9 | · | -2.1 | -2.9 | -2.8 | · | · | |
| P/S | · | · | · | 6.2 | 4.1 | 3.0 | · | 2.0 | 1.5 | 2.4 | · | 5.1 | 7.8 | 9.4 | · | 14.4 | |
| P/B | 1.4 | 1.4 | · | 0.6 | 0.5 | 0.4 | · | 0.7 | 0.5 | 0.6 | · | 1.0 | 1.3 | 1.2 | · | 2.0 | |
| P / Tangible Book | 1.4 | 1.4 | · | 0.6 | 0.5 | 0.4 | · | 0.7 | 0.5 | 0.6 | · | 1.0 | 1.3 | 1.2 | · | 2.0 | |
| P / Cash Flow | · | -7.3 | · | · | · | -7.0 | · | · | · | -2.9 | · | · | · | -8.3 | · | · | |
| Earnings Yield | -41.9% | -71.9% | · | 6.8% | -3.7% | 8.4% | · | -110.7% | -165.8% | -109.0% | · | -47.9% | -35.1% | -35.9% | · | · |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $7M | $26M | $24M | $15M | $14M |
| Margen Operativo % | -1601.1% | -259.6% | -295.4% | -411.9% | -9930.1% |
| Beneficio neto | $-21M | $-64M | $-66M | $-61M | $-110M |
| EPS Diluido | $-0.33 | $-2.36 | $-2.44 | $-2.69 | $-12.41 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 10.3 | 3.6 | 4.7 | 9.6 | 9.9 |
| Ratio Rápido | 10.0 | 3.1 | 4.3 | 9.3 | 9.8 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-98M | $-61M | $-64M | $-50M | $-22M |
Propietarios institucionales (13F) 82 declarantes · $202.4M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
82
Valor en tenencia
$202.4M
Nuevas posiciones
28
Posiciones cerradas
11
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 28 (+6 vs trimestre anterior) | 11 (+7 vs trimestre anterior) | 30 (+15 vs trimestre anterior) | 10 (+2 vs trimestre anterior) | +9.0M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| Yu Fan | $22 264 818 | 4 861 314 | 11,00% | Acciones |
| ACUTA CAPITAL PARTNERS, LLC | $21 461 477 | 4 685 912 | 10,60% | Acciones |
| QVT Financial LP | $21 139 947 | 4 615 709 | 10,44% | Acciones |
| MONTANOVA CAPITAL, LLC | $19 694 000 | 4 300 000 | 9,73% | Acciones |
| ORBIMED ADVISORS LLC | $18 019 076 | 3 934 296 | 8,90% | Acciones |
| Avoro Capital Advisors LLC | $13 050 261 | 2 849 402 | 6,45% | Acciones |
| Siren, L.L.C. | $10 703 927 | 2 337 102 | 5,29% | Acciones |
| KVP Capital Advisors, LP | $9 920 266 | 2 165 997 | 4,90% | Acciones |
| BlackRock, Inc. | $8 806 552 | 1 922 828 | 4,35% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $6 359 609 | 1 388 561 | 3,14% | Acciones |
| ADAR1 Capital Management, LLC | $6 143 585 | 1 341 394 | 3,04% | Acciones |
| ACORN CAPITAL ADVISORS, LLC | $5 218 283 | 1 139 363 | 2,58% | Acciones |
| STEMPOINT CAPITAL LP | $4 676 349 | 1 021 037 | 2,31% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $4 121 928 | 899 780 | 2,04% | Acciones |
| VANGUARD GROUP INC | $3 848 082 | 1 590 117 | 1,90% | Acciones |
| Ally Bridge Group (NY) LLC | $3 746 161 | 817 939 | 1,85% | Acciones |
| Woodline Partners LP | $1 999 692 | 436 614 | 0,99% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $1 895 305 | 413 822 | 0,94% | Acciones |
| STATE STREET CORP | $1 772 378 | 386 982 | 0,88% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $1 742 259 | 380 406 | 0,86% | Acciones |
| Eversept Partners, LP | $1 389 141 | 303 306 | 0,69% | Acciones |
| Verdad Advisers, LP | $1 380 792 | 301 483 | 0,68% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $1 358 483 | 296 612 | 0,67% | Acciones |
| AMES NATIONAL CORP | $1 333 269 | 4 571 | 0,66% | Acciones |
| Balyasny Asset Management L.P. | $1 319 576 | 288 117 | 0,65% | Acciones |
| NORTHERN TRUST CORP | $1 212 276 | 264 689 | 0,60% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $1 130 834 | 246 907 | 0,56% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 004 014 | 219 217 | 0,50% | Acciones |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $757 001 | 165 284 | 0,37% | Acciones |
| GOLDMAN SACHS GROUP INC | $580 552 | 126 758 | 0,29% | Acciones |
| Bank of New York Mellon Corp | $378 455 | 82 632 | 0,19% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $361 051 | 78 832 | 0,18% | Acciones |
| Point72 Asset Management, L.P. | $261 651 | 57 129 | 0,13% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $237 427 | 51 840 | 0,12% | Acciones |
| UBS Group AG | $232 851 | 50 841 | 0,12% | Acciones |
| Qube Research & Technologies Ltd | $224 388 | 48 993 | 0,11% | Acciones |
| Nuveen, LLC | $200 599 | 43 799 | 0,10% | Acciones |
| Jump Financial, LLC | $186 864 | 40 800 | 0,09% | Acciones |
| Invesco Ltd. | $179 440 | 39 179 | 0,09% | Acciones |
| BANK OF AMERICA CORP /DE/ | $158 587 | 34 626 | 0,08% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $153 064 | 33 420 | 0,08% | Acciones |
| DEUTSCHE BANK AG\ | $145 039 | 31 668 | 0,07% | Acciones |
| CITADEL ADVISORS LLC | $137 794 | 30 086 | 0,07% | Acciones |
| MORGAN STANLEY | $137 309 | 29 980 | 0,07% | Acciones |
| WELLS FARGO & COMPANY/MN | $124 457 | 27 174 | 0,06% | Acciones |
| RHUMBLINE ADVISERS | $112 338 | 24 529 | 0,06% | Acciones |
| Y-Intercept (Hong Kong) Ltd | $111 583 | 24 363 | 0,06% | Acciones |
| TWO SIGMA ADVISERS, LP | $102 608 | 42 400 | 0,05% | Acciones |
| Vanguard Global Advisers, LLC | $89 205 | 19 477 | 0,04% | Acciones |
| NEW YORK STATE COMMON RETIREMENT FUND | $85 646 | 18 700 | 0,04% | Acciones |
Activistas y propietarios del %+ 5 13 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC, ANUPAM DALAL, Acuta Capital Fund, LP ×3 presentaciones | 18 de mayo de 2026 | 9,00% | Enmienda | Inversión pasiva | SEC |
| Avoro Capital Advisors LLC, Avoro Ventures LLC, Behzad Aghazadeh ×6 presentaciones | 14 de mayo de 2026 | 19,99% | Enmienda | · | SEC |
| Neil Desai ×5 presentaciones | 6 de marzo de 2025 | 4,90% | Enmienda | · | SEC |
| BML Investment Partners, L.P., Leonard Braden Michael ×5 presentaciones | 5 de marzo de 2025 | 4,98% | Enmienda | Inversión pasiva | SEC |
| Muneer A. Satter (2) ×5 presentaciones | 12 de noviembre de 2021 | · | Presentación inicial | · | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP V LLC ×4 presentaciones | 3 de septiembre de 2021 | · | Presentación inicial | · | SEC |
| Novartis Bioventures Ltd., Novartis AG ×7 presentaciones | 15 de mayo de 2020 | · | Presentación inicial | · | SEC |
| Kearny Venture Partners, L.P. (“KVP”), Kearny Venture Partners Entrepreneurs’ Fund, L.P. (“KVPE”), Kearny Venture Associates, L.L.C. (“KVA”), Caley Castelein (“Castelein”), Richard Spalding (“Spalding”), James Shapiro (“Shapiro”) ×2 presentaciones | 4 de octubre de 2018 | · | Presentación inicial | · | SEC |
| Novartis Bioventures Ltd. (2), Novartis AG (2) | 27 de marzo de 2017 | · | Presentación inicial | · | SEC |
| Venture Investors Early Stage Fund IV Limited Partnership (2), VIESF IV GP LLC (2) | 27 de marzo de 2017 | · | Presentación inicial | · | SEC |
| Persona informante no revelada | 4 de abril de 2008 | · | Presentación inicial | · | SEC |
| Persona informante no revelada | 4 de abril de 2008 | · | Presentación inicial | · | SEC |
| Argyris Vassiliou | 4 de abril de 2008 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 28 insiders · 12 directivos · 17 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| David James Lennon | CHIEF EXECUTIVE OFFICER | 15 de septiembre de 2026 A | 569 643 | 0 | 6 | $-1 058 894 |
| Brendan Delaney | President and Chief Executive Officer | 1 de marzo de 2023 A | 20 000 | 0 | 0 | $0 |
| Stephen J Hoffman | Chief Executive Officer | 14 de mayo de 2019 A | 31 967 | 0 | 0 | $0 |
| Scott M. Giacobello | CHIEF FINANCIAL OFFICER | 15 de septiembre de 2026 A | 333 489 | 0 | 3 | $-890 614 |
| Joseph H. Gardner | President | 16 de marzo de 2020 A | 453 019 | 0 | 0 | $0 |
| Margaret Dugan | Chief Medical Officer | 15 de septiembre de 2026 A | 19 132 | 0 | 0 | $0 |
| David Dornan | Chief Scientific Officer | 15 de septiembre de 2026 A | · | 0 | 0 | $0 |
| Bryan Ball | Chief Technical Operations Officer | 15 de septiembre de 2026 A | 448 126 | 0 | 5 | $-635 055 |
| Lorettta M Itri | CHIEF MEDICAL OFFICER | 1 de marzo de 2024 A | · | 0 | 0 | $0 |
| Kevin G. Peters | Chief Scientific Officer and Acting Chief Medical Officer Exhibit 24: Power of Attorney | 16 de marzo de 2020 A | 320 536 | 0 | 0 | $0 |
| Michael W Rogers | Chief Financial and Chief Business Officer | 14 de mayo de 2019 A | · | 0 | 0 | $0 |
| Steve Pakola | Chief Medical Officer | 15 de febrero de 2019 A | · | 0 | 0 | $0 |
| Vijay K Iyengar | Consejero | 9 de septiembre de 2026 A | · | 0 | 0 | $0 |
| Baiteng Zhao | Consejero | 12 de junio de 2026 A | 1 250 000 | 0 | 0 | $0 |
| Neil Desai | Consejero | 12 de junio de 2026 A | 1 211 543 | 0 | 0 | $0 |
| Emma Reeve | Consejero | 12 de junio de 2026 A | · | 0 | 0 | $0 |
| Mohammad Hirmand | Consejero | 12 de junio de 2026 A | · | 0 | 0 | $0 |
| Anupam Dalal | Consejero | 12 de junio de 2026 A | 4 685 912 | 0 | 0 | $0 |
| Richard E Maroun | Consejero | 12 de junio de 2026 A | · | 0 | 0 | $0 |
| Caley Castelein | Consejero | 12 de junio de 2026 A | 274 796 | 0 | 0 | $0 |
| Karin M. Hehenberger | Consejero | 12 de junio de 2024 A | · | 0 | 0 | $0 |
| Cheryl Cohen | Consejero | 17 de junio de 2021 A | 8 020 | 0 | 0 | $0 |
| Chau Quang Khuong | Consejero | 18 de junio de 2019 A | 5 193 946 | 0 | 0 | $0 |
| Satter Muneer A | Consejero | 18 de junio de 2019 A | 5 621 835 | 0 | 0 | $0 |
| Paul M Weiss | Consejero | 15 de marzo de 2017 P | 1 576 167 | 0 | 0 | $0 |
| Dugel Pravin | · | 30 de junio de 2021 A | 12 568 | 0 | 0 | $0 |
| Steven Prelack | · | 30 de junio de 2021 A | 24 485 | 0 | 0 | $0 |
| Regina Marek | · | 16 de marzo de 2020 A | · | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 10 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,43% | 26 402 SH | 1 de octubre de 2026 | Diario |
| IWC · iShares Trust | 0,03% | 109 848 SH | 11 de septiembre de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 28 211 SH | 19 de agosto de 2026 | Diario |
| RSSL · Global X Funds | 0,00% | 15 506 NS | 31 de julio de 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 720 704 SH | 11 de septiembre de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 470 854 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 887 972 SH | 19 de agosto de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 187 597 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 409 SH | 19 de agosto de 2026 | Diario |
| IWN · iShares Trust | · | 311 545 SH | 11 de septiembre de 2026 | Diario |
WHWK Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 14 analistas
COMPRA
Objetivo mediano
$8.00
+116,2%
4 28,6%
Compra fuerte
6 42,9%
Compra
4 28,6%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
7 analistas · 2026-10-03Objetivo medio $7.71 +108,5%
← Por Debajo de Todos los Objetivos
Precio Actual $3.70
Mín$4.00
Media$7.71
Máx$10.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | · |
| RNAC | $188M | -1.4 | -92.8% | -4658.6% | 202.4% | · |
| SION | $1.84B | -21.9 | · | · | -23.4% | · |
| TRDA | $394M | -3.0 | -87.9% | -565.5% | -41.9% | · |
| ELDN | $114M | -2.9 | · | · | -69.4% | · |
| ALEC | $172M | -1.1 | -79.1% | -679.2% | -280.7% | · |
| CUE | $29M | -1.1 | 195.8% | -96.9% | -119.3% | · |
| NKTX | $131M | -1.3 | · | · | -31.1% | · |
| CNTN | $112M | -2.7 | · | · | -18.0% | · |
| CHRS | $172M | 1.0 | 59.8% | 398.4% | 185.8% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 6, 2026